With key players AbbVie, Pfizer, GlaxoSmithKline and others

Featuring key players 3M, Becton, Dickinson, and Co, Medtronic and others


company logo

company logo

Dublin, September 16, 2022 (GLOBE NEWSWIRE) — “Global Surgical Sealants Market Research & Forecast 2022-2028” report added to ResearchAndMarkets.com offering.

The global surgical sealants market is anticipated to grow at a CAGR of 9.7% during the forecast period. Surgical sealants are used to repair elastic and soft tissues, such as wounds, lungs, and the heart, among others. It prevents tissue leakage by joining them, internally and externally, during an injury or after surgery.

Sealants are made from natural or synthetic materials such as gelatin, fibrin, albumin, and polyethylene glycol (PEG) polymers. Surgical sealants and adhesives have been used significantly over conventional approaches used for wound closure, such as staples and sutures.

Surgical sealants have been increasingly adopted by surgeons in cardiovascular surgery, pulmonary surgery, orthopedic surgery, and ophthalmic surgery, among others. The various advantages associated with surgical sealants, such as safety, ease of use, and efficacy in various conditions on different tissues. In addition, it promotes wound healing and significantly eliminates the need for sutures and staples.

The growing awareness of the benefits of surgical sealants in surgical procedures and the increasing number of surgical procedures due to the sedentary lifestyle and faulty dietary habits of the adult population in the US is greatly driving the growth of the global market for surgical sealants. In addition to the increasing prevalence of chronic diseases, the number of surgeries has increased as most chronic diseases in later stages require surgery. For example, according to Dementia Australia, around 459,000 Australians were living with dementia in 2020, and around 1.6 million were involved in its care setting. It is estimated that it will reach 1.1 million by 2058.

The high cost associated with surgical sealants and adhesives in low- and middle-income economies is the main factor restraining the growth of the global surgical sealants market. Side effects associated with sealants and adhesives, stringent regulatory policies, low surgical incision closure force, and availability of cheaper alternative products such as sutures and staples are some of the factors limiting the growth of the global market. of surgical sealants. However, the rising prevalence of chronic diseases such as cancer and heart disease, a significant increase in the number of FDA approvals, and increased investments from major players in emerging economies are likely to drive market growth. in the near future.

The report covers

  • 2020 Market Value Data Analysis and Forecast to 2027.

  • Annualized market revenue ($ million) for each market segment.

  • Analysis by country of the main geographic regions.

  • Key companies operating in the global surgical sealants market. Subject to data availability, information related to new product launches and relevant news is also available in the report.

  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.

  • Analysis of market entry and expansion strategies.

  • Competitive strategies identifying ‘who-is-where’ in the market.

Key Topics Covered:

1. Summary of the report

2. Market overview and information

3. Competitive landscape

4. Market determinants

5. Market segmentation

6. Regional Analysis

7. Company profiles

1. 3M company

2. Adhesys Medical GmbH

3. Biomedical Adhesion

4. Advanced Medical Solutions Group Plc

5. Arch Therapeutics, Inc.

6. Asahi Kasei Corp.

7. B. Braun Melsungen AG

8. Baxter International, Inc.

9. Becton, Dickinson and company (BD)

10. Cardinal Health, Inc.

11. Cohera Medical, Inc.

12. CryoLife, Inc.

13. CSL Ltd.

14. Endomedix

15. Ethicon USA, LLC (Johnson & Johnson)

16. Grunenthal GmbH

17.Integra Life Sciences Corp.

18. Kuros Biosciences Ltd.

19. Mallinckrodt Plc

20. Medtronic Plc

21. Eye Therapy, Inc.

22. Pfizer Inc.

23. Polyganism

24. Stryker Corporation.

25. Takeda Pharmaceutical Co. Ltd.

26. Teijin Ltd.

27. Tissuemed ​​Ltd.

28. The latest in dentistry

29. Vivostat A/S

For more information on this report, please visit https://www.researchandmarkets.com/r/u93apr

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Source link